Postprandial lipoproteins and the molecular regulation of vascular homeostasis

Progress in Lipid Research

Volumn 52, Issue 4, 2013, Pages 446-464

  Botham, Kathleen M ^a   Wheeler Jones, Caroline P D ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Endothelial cells; Inflammation; Macrophages; Monocytes; Postprandial lipemia; Triglyceride rich lipoproteins

Indexed keywords

CELL ADHESION MOLECULE; CYCLOOXYGENASE 2; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; TRANSCRIPTION FACTOR NRF2; TRIGLYCERIDE RICH LIPOPROTEIN; UNCLASSIFIED DRUG;

ARTERY WALL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL FUNCTION; CELL FUNCTION; CELL TYPE; CLEARANCE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FAT INTAKE; FOAM CELL; HOMEOSTASIS; HUMAN; HYPERLIPIDEMIA; INFLAMMATION; INFLAMMATORY DISEASE; INTRACELLULAR SIGNALING; LEUKOCYTE MIGRATION; LIPOPROTEIN BLOOD LEVEL; MACROPHAGE; NONHUMAN; PATHOPHYSIOLOGY; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RISK FACTOR; SIGNAL TRANSDUCTION; VASCULAR CELL; VASCULAR HOMEOSTASIS;

1-PALMITOYL-2-ARACHIDONYL-SN-GLYCEROL-3-PHOSPHOCHOLINE; ABC; ACTIVATOR PROTEIN; AKT; ALTERNATIVELY ACTIVATED MACROPHAGES; AMP KINASE; AMPK; AP; APO; APOB48R; APOLIPOPROTEIN; APOLIPOPROTEIN B48 RECEPTOR; ATP BINDING CASSETTE TRANSPORTER; C REACTIVE PROTEIN; C-JUN N-TERMINAL KINASE; CAMP RESPONSE ELEMENT BINDING; CD; CHYLOMICRON REMNANTS; CHYLOMICRONS; CLASSICALLY ACTIVATED MACROPHAGES; CLUSTER OF DIFFERENTIATION; CM; CMR; COX; CREB; CRP; CYCLOOXYGENASE; DHA; DOCOSAHEXAENOIC ACID; EARLY GROWTH RESPONSE PROTEIN; EC; EGF; EGR; EICOSAPENTAENOIC ACID; ENDOTHELIAL CELL; ENDOTHELIAL CELLS; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIAL PROGENITOR CELL; ENOS; EPA; EPC; EPIDERMAL GROWTH FACTOR; ERK; EXTRACELLULAR-SIGNAL-REGULATED KINASE; FAK; FFA; FOCAL ADHESION KINASE; FREE FATTY ACID; GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED HIGH DENSITY LIPOPROTEIN BINDING PROTEIN 1; GPIHBP1; HAEC; HDL; HEMEOXYGENASE; HEPARAN SULFATE PROTEOGLYCANS; HIGH DENSITY LIPOPROTEIN; HMDM; HO; HSPG; HUMAN AORTIC ENDOTHELIAL CELL; HUMAN MONOCYTE-DERIVED MACROPHAGES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUVEC; ICAM; IFN; IL; INFLAMMATION; INHIBITOR OF ΚB; INTERCELLULAR ADHESION MOLECULE; INTERFERON; INTERLEUKIN; IΚB; JNK; LDL; LDLR; LECTIN-LIKE OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR; LIPOPOLYSACCHARIDE; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN; LOX; LPL; LPS; LR11; LRP; M1; M2; MACROPHAGE INFLAMMATORY PROTEIN; MACROPHAGE PHENOTYPE INDUCED BY OXIDISED PHOSPHOLIPIDS; MACROPHAGES; MAPK; MATRIX-METALLOPROTEINASE; MCP; MEK; MIP; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN-ACTIVATED KINASE; MMP; MONOCYTE CHEMOATTRACTANT PROTEIN; MONOCYTES; MONOUSATURATED FATTY ACIDS; MOX; MUFA; NAD(P)H OXIDASE; NF-ΚB; NITRIC OXIDE; NO; NOX; NRF; NUCLEAR FACTOR (ERYTHROID-DERIVED 2)-LIKE 2; NUCLEAR FACTOR-ΚB; OX; OXIDIZED; P; PAI-1; PAPC; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; PGE(2); PHOSPHOLIPID; PKC; PL; PLASMINOGEN ACTIVATOR INHIBITOR TYPE 1; POA; POLYUNSATURATED FATTY ACIDS; POMACE OIL SUPPLEMENTED WITH OLEANOLIC ACID TEST MEAL; POMACE OLIVE OIL TEST MEAL; POSTPRANDIAL LIPEMIA; PPAR; PROSTGLANDIN E2; PROTEIN KINASE B; PROTEIN KINASE C; PUFA; RAP; REACTIVE OXYGEN SPECIES; RECEPTOR ASSOCIATED PROTEIN; REMNANT-LIKE PARTICLES; RETINOID X RECEPTOR; RLP; ROS; RXR; SATURATED FATTY ACIDS; SCAVENGER RECEPTOR; SFA; SORTILIN-RELATED RECEPTOR; SR; TG; TGF; TLR; TNF; TOLL-LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR; TRIACYLGLYCEROL; TRIGLYCERIDE-RICH LIPOPROTEINS; TRL; TUMOR NECROSIS FACTOR; V; VASCULAR CELL ADHESION MOLECULE; VASCULAR ENDOTHELIAL CADHERIN; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR SMOOTH MUSCLE CELLS; VCAM; VE CADHERIN; VEGF; VERY LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN RECEPTOR; VIRGIN OLIVE OIL TEST MEAL; VLDL; VLDLR; VSMC;

ATHEROSCLEROSIS; FOAM CELLS; HUMANS; LIPOPROTEINS; MACROPHAGES; MONOCYTES; MUSCLE, SMOOTH, VASCULAR; TRIGLYCERIDES;

EID: 84879831707     PISSN: 01637827     EISSN: 18732194     Source Type: Journal    
DOI: 10.1016/j.plipres.2013.06.001     Document Type: Review

References (214)

1. E. Braunwald Shattuck lecture-cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities N Engl J Med 337 1997 1360 1369
2. S. Allender, P. Scarborough, V. Peto, M. Raynor, J. Leal, and Luengo-Fernandez European cardiovascular disease statistics 2008 edition 2008 European Heart Network http://www.ehnheart.org/cvd-statistics.html
3. V.L. Roger, A.S. Go, D.M. Lloyd-Jones, E.J. Benjamin, J.D. Berry, and W.B. Borden AHA statistical update. Heart disease and stroke statistics-2012 update Circulation 125 2012 e2 e220
4. R. Ross The pathogenesis of atherosclerosis: a perspective for the 1990s Nature 362 1993 801 809
5. A. Kadar, and T. Glasz Development of atherosclerosis and plaque biology Cardiovasc Surgery 9 2001 109 121
6. R. Albertini, R. Moratti, and G. DeLuca Oxidation of low-density lipoprotein in atherosclerosis from basic biochemistry to clinical studies Curr Mol Med 2 2002 579 592
7. M. Soufi, A.M. Sattler, B. Maisch, and J.R. Schaefer Molecular mechanisms involved in atherosclerosis Herz 27 2002 637 648
8. P. Libby, P.M. Ridker, and G.K. Hansson Progress and challenges in translating the biology of atherosclerosis Nature 473 2011 317 325
9. T. Goyal, S. Mitra, M. Khaidakov, X. Wang, S. Singla, and Z. Ding Current concepts of the role of oxidized LDL receptors in atherosclerosis Curr Atheroscler Rep 2012 [Epub ahead of print]
10. S. Bansal, J.E. Buring, N. Rifai, S. Mora, F.M. Sacks, and P.M. Ridker Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women JAMA 298 2007 309 316
11. S. Mora, N. Rifai, J.E. Buring, and P.M. Ridker Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events Circulation 118 2008 993 1001
12. K.G. Jackson, S.D. Poppit, and A.M. Minihane Postprandial lipoproteins and cardiovascular disease risk: interelationships between dietary, physiological and gentic determinants Atherosclerosis 220 2012 22 33
13. C. Dubois, G. Beaumier, C. Juhel, M. Armand, H. Portugal, and A.M. Pauli Effects of graded amounts (0-50 g) of dietary fat on postprandial lipemia and lipoproteins in normolipidemic adults Am J Clin Nutr 67 1998 31 38
14. E. Bravo, M. Napolitano, and K.M. Botham Postprandial lipid metabolism: the missing link between life-style habits and the increasing incidence of metabolic diseases in western countries? Open Trans Med J 2 2010 1 13 10.2174/1876399501002010001
15. A.R. Sharrett, G. Heiss, L.E. Chambless, E. Boerwinkle, S.A. Coady, and A.R. Folsom Metabolic and lifestyle determinants of postprandial lipemia differ from those of fasting triglycerides Arterioscler Thromb Vasc Biol 21 2001 275 281
16. T.G. Redgrave Formation and metabolism of chylomicrons Int Rev Physiol 28 1983 103 130
17. K.C. Yu, and A.D. Cooper Postprandial lipoproteins and atherosclerosis Front Biosci 6 2001 D332 D354
18. P. Nguyen, V. Leray, M. Diez, S. Serisier, J. Le Bloc'h, and B. Siliart Liver lipid metabolism J Anim Physiol Anim Nutr (Berl) 92 2008 272 283
19. G.F. Gibbons Assembly and secretion of hepatic very-low-density lipoprotein Biochem J 268 1990 1 13
20. P. Libby, P.M. Ridker, and A. Maseri Inflammation in atherosclerosis Circulation 105 2002 1135 1145
21. P. Libby Inflammation in atherosclerosis Nature 2002 420 2002 868 874
22. A.N. Margioris Fatty acids and postprandial inflammation Curr Opin Nutr Metab Care 12 2008 129 137
23. P. Libby Fat fuels the flame - triglyceride-rich lipoproteins and arterial inflammation Circ Res 100 2007 299 301
24. H.J. Ting, J.P. Stice, U.Y. Schaff, D.Y. Hui, J.C. Rutledge, and A.A. Knowlton Triglyceride-rich lipoproteins prime aortic endothelium for an enhanced inflammatory response to tumor necrosis factor-alpha Circ Res 100 2007 381 390
25. P.M. Vanhoutte, H. Shimokawa, E.H. Tang, and M. Feletou Endothelial dysfunction and vascular disease Acta Physiol 196 2009 193 222
26. J. Dalla-Riva, E. Garonna, J. Elliott, K.M. Botham, and C.P. Wheeler-Jones Endothelial cells as targets for chylomicron remnants Atheroscler Suppl 11 2010 31 37
27. C.P. Wheeler-Jones Chylomicron remnants: mediators of endothelial dysfunction? Biochem Soc Trans 35 2007 442 445
28. D.B. Zilversmit Atherogenesis: a postprandial phenomenon Circulation 60 1979 473 485
29. A. Alipour, J.W.F. Elte, H.C.T. van Zaanen, A.P. Rietveld, and M. Castro Cabezas Novel aspects of postprandial lipemia in relation to atherosclerosis Atheroscler Suppl 9 2008 39 44
30. J.H. O'Keefe, and D.S.H. Bell Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor Am J Cardiol 100 2007 899 904
31. D. Hyson, J.C. Rutledge, and L. Berglund Postprandial lipemia and cardiovascular disease Curr Atheroscler Rep 5 2003 437 444
32. I.J. Goldberg, R.H. Eckel, and R. McPherson Triglycerides and heart disease: still a hypothesis? Arterioscler Thromb Vasc Biol 31 2011 1716 1725
33. J. Lopez-Miranda, C. Williams, and D. Lairon Dietary, physiological, genetic and pathological influences on postprandial lipid metabolism Br J Nutr 98 2007 458 473
34. F. Karpe, G. Steiner, K. Uffelman, T. Olivecrona, and A. Hamsten Postprandial lipoproteins and progression of coronary atherosclerosis Atherosclerosis 106 1994 83 97
35. P.H. Groot, W.A. van Stiphout, X.H. Krauss, H. Jansen, A. van Tol, and E. van Ramshorst Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease Arterioscler Thromb 11 1991 653 662
36. J.R. Patsch, G. Miesenbock, and W. Patsch Relation of triglyceride metabolism and coronary disease. Studies in the postprandial state Arterioscler Thromb 12 1992 1336 1345
37. K.M. Botham, E. Bravo, J. Elliott, and C.P.D. Wheeler-Jones Direct interaction of dietary lipids carried in chylomicron remnants with cells of the artery wall: implications for atherosclerosis development Curr Pharmaceut Design 11 2005 3681 3695
38. S. Pastromas, A.B. Terzi, D. Tousoulis, and S. Koulouris Postprandial lipemia: an under-recognized atherogenic factor in patients with diabetes mellitus Int J Cardiol 126 2008 3 12
39. B. Klop, S. Proctor, J.C.L. Mamo, K.M. Botham, and M. Castro Cabezas Understanding postprandial inflammation and its relationship to lifestyle behaviour and metabolic diseases Int J Vasc Med 2012 [article ID 947417, doi: http://dx.doi.org/10.1155/2012/947417 ]
40. S. Takeichi, Y. Nakajima, N. Yukawa, T. Saito, Y. Seto, and X.L. Huang Association of plasma triglyceride-rich lipoprotein remnants with "Pokkuri disease" Legal Med 3 2001 84 94
41. K. Nakajima, Y. Nakajima, S. Takeichi, and M.Q. Fujita Plasma remnant-like lipoprotein particles or LDL-C as major pathologic factors in sudden cardiac death cases Atherosclerosis 198 2008 237 246
42. B.G. Nordestgaard, M. Benn, P. Schnohr, and A. Tybjaerg-Hansen Non fasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women JAMA 298 2007 299 308
43. A.S. Lindman, M.B. Veierod, A. Tverdal, J.I. Pederson, and R. Selmer Nonfasting triglycerides and risk of cardiovascular death in men and women from the Norwegian countries study Eur J Epidemiol 25 2010 789 798
44. S. Boquist, G. Ruotolo, R. Tang, J. Björkegren, M.G. Bond, and U. de Faire Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men Circulation 100 1999 723 728
45. E. ter Avest, S. Holewijn, S.J. Bredie, A.F. Stalenhoef, and J. de Graaf Remnant particles are the major determinant of an increased intima media thickness in patients with familial combined hyperlipidemia (FCH) Atherosclerosis 191 2007 220 226
46. Y. Misuguchi, T. Ito, and K. Owada Pathologic findings in rabbit models of hereditary hypertriglyceridemia and hereditary postprandial hypertriglyceridemia Comp Med 58 2008 465 480
47. S. Fazio Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy Clin Ther 30 2008 294 306
48. P. Deedwania, P. Barter, R. Carmena, J.C. Fruchart, S.M. Grundy, and S. Haffner Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the treating to new targets study Lancet 368 2006 919 928
49. M.G. Wilhelm, and A.D. Cooper Induction of atherosclerosis by human chylomicron remnants: a hypothesis J Atheroscler Thromb 10 2003 132 139
50. A.F.H. Stalenhoef, and J. de Graaf Association of fasting and non fasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small dense LDL Curr Opin Lipidol 19 2008 355 361
51. D. Noto, M. Rizzo, C.M. Barbagallo, A.B. Cefalù, A.L. Verde, and F. Fayer Low-density lipoproteins generated during an oral fat load in mild hypertrigyceridemic and healthy subjects are smaller, denser and have an increased low-density lipoprotein receptor binding affinity Metabolism 55 2006 1308 1316
52. S. Koba, F. Tsunoda, T. Hirano, Y. Iso, H. Suzuki, and E. Geshi Postprandial changes in LDL phenotypes in patients with myocardial infarction Eur J Clin Invest 35 2005 171 179
53. P. Blackburn, M. Cote, B. Lamarche, C. Couillard, A. Pascot, and A. Tremblay Impact of postprandial variation in triglyceridemia on low-density lipoprotein particle size Metabolism 52 2003 1379 1386
54. C.J. Packard Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular disease Curr Opin Lipidol 17 2006 412 417
55. M. Rizzo, and K. Berneis Lipid triad or atherogenic lipoprotein phenotype: a role in cardiovascular prevention? J Atheroscler Thromb 12 2005 237 239
56. S. Pal, K. Semorine, G.F. Watts, and J. Mamo Identification of lipoproteins of intestinal origin in human atherosclerotic plaque Clin Chem Lab Med 41 2003 792 795
57. J.H. Rapp, A. Lespine, R.L. Hamilton, N. Colwas, A.H. Chaumetaon, and J. Tweedie-Harman Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque Arterioscler Thromb 14 1994 1767 1774
58. B.H. Chung, G. Tallis, V. Yalamoori, G.M. Anantharamaiah, and J.P. Segrest Liposome-like particles isolated from human atherosclerotic plaques are structurally and compositionally similar to surface remnants of triglyceride rich lipoproteins Arterioscler Thromb 14 1994 622 635
59. S.D. Proctor, D.F. Vine, and J.C.L. Mamo Arterial retention of apolipoprotein B(48)- and B(100)-containing lipoproteins in atherosclerosis Curr Opin Lipidol 13 2002 461 470
60. S.D. Proctor, and J.C. Mamo Intimal retention of cholesterol derived from apolipoprotein B100- and apolipoprotein B48-containing lipoproteins in carotid arteries of Watanabe heritable hyperlipidemic rabbits Arterioscler Thromb Vasc Biol 23 2003 1595 1600
61. S.D. Proctor, D.F. Vine, and J.C.L. Mamo Arterial permeability and efflux of apolipoprotein B-containing lipoproteins assessed by in situ perfusion and three-dimensional quantitative confocal microscopy Arterioscler Thromb Vasc Biol 24 2004 2162 2167
62. J.S. Perona, R. Cabello Moruno, and V. Ruiz-Gutierrez Modulation of the effects of chylomicron remnants on endothelial function by minor dietary lipid components Biochem Soc Trans 35 2007 446 450
63. G.D. Norata, and A.L. Catapano Triglyceride-rich lipoproteins from normotrygliceridemic subjects and hyperlipidemic patients differently affect endothelial cell activation and gene expression patterns Circ Res 100 2007 381 390
64. G.D. Norata, L. Grigore, S. Raselli, P.M. Seccomandi, A. Hamsten, and F.M. Maggi Triglyceride-rich lipoproteins from hypertriglyceridemic subjects induce a pro-inflammatory response in the endothelium: molecular mechanisms and gene expression studies J Mol Cell Cardiol 40 2006 484 494
65. K.M. Botham, E.H. Moore, C. De Pascale, and F. Bejta The induction of macrophage foam cells by chylomicron remnants Biochem Soc Trans 35 2007 454 458
66. C. Bentley, N. Hathaway, J. Widdows, F. Bejta, C. De Pascale, and M. Avella Influence of chylomicron remnants on human monocyte activation in vitro Nutr Metab Cardiovasc Dis 21 2012 871 878
67. D.A. Hyson, T.G. Paglieroni, T. Wun, and J.C. Rutledge Postprandial lipemia is associated with platelet and monocyte activation and increased monocyte cytokine expression in normolipemic men Clin Appl Thromb Hemost 8 2002 147 155
68. G.J. Miller, J.C. Martin, K.A. Mitropoulos, B.E. Reeves, R.L. Thompson, and T.W. Meade Plasma factor VII is activated by postprandial triglyceridaemia, irrespective of dietary fat composition Atherosclerosis 86 1991 163 171
69. C.D. Byrne, N.J. Wareham, N.D. Martensz, S.E. Humphries, J.C. Metcalfe, and D.J. Grainger Increased PAI activity and PAI-1 antigen occurring with an oral fat load: associations with PAI-1 genotype and plasma active TGF-β levels Atherosclerosis 140 1998 45 53
70. B. Fuhrman, J.G. Brook, and M. Aviram Increased platelet aggregation during alimentary hyperlipemia in normal and hypertriglyceridemic subjects Ann Nutr Metab 30 1986 250 260
71. T. Olivecrona, and G. Olivecrona Triglyceride lipases and atherosclerosis Curr Opin Lipidol 21 2010 409 415
72. M.H. Doolittle, N. Ehrhardt, and M. Péterfy Lipase maturation factor 1: structure and role in lipase folding and assembly Curr Opin Lipidol 21 2010 198 203
73. G.M. Dallinga-Thie, R. Franssen, H.L. Mooij, M.E. Visser, H.C. Hassing, and F. Peelman The metabolism of triglyceride-rich lipoproteins revisited: new players, new insights Atherosclerosis 211 2010 1 8
74. S.G. Young, B.S. Davies, C.V. Voss, P. Gin, M.M. Weinstein, and P. Tontonoz GPIHBP1, an endothelial cell transporter for lipoprotein lipase J Lipid Res 52 2011 1869 1884
75. S.G. Young, B.S. Davies, L.G. Fong, P. Gin, M.M. Weinstein, and A. Bensadoun GPIHPB1, an endothelial cell molecule important for the lipolytic processing of chylomicrons Curr Opin Lipidol 18 2007 389 396
76. I. Staprans, X.M. Pan, M. Miller, and J.H. Rapp The effect of oxidation on the chylomicron metabolism in rats Am J Physiol 27 1993 G561 G568
77. R. Wilson, K. Lyall, L. Smyth, C.E. Fernie, and R.A. Riemersma Dietary hydroxy fatty acids are absorbed in humans: implications for the measurement of 'oxidative stress' in vivo Free Radic Biol Med 32 2002 162 168
78. D. Lairon, B. Play, and D. Jourdheuil-Rahmani Digestible and indigestible carbohydrates: interactions with postprandial lipid metabolism J Nutr Biochem 18 2007 217 227
79. A. Zampelas, A.S. Peel, B.J. Gould, J. Wright, and C.M. Williams Polyunsaturated fatty acids of the n-6 and n-3 series: effects on postprandial lipid and apolipoprotein levels in healthy men Eur J Clin Nutr 48 1994 842 848
80. A. Mente, L. de Koning, H.S. Shannon, and S.S. Anand A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease Arch Intern Med 169 2009 659 669
81. A.E. Jiménez-Corona, S. Damián-Zamacona, A. Pérez-Torres, A. Moreno, and J. Mas-Oliva Osteopontin upregulation in atherogenesis is associated with cellular oxidative stress triggered by the activation of scavenger receptors Arch Med Res 43 2012 102 111
82. K. Domoto, T. Taniguchi, H. Takaishi, T. Takahashi, Y. Fujioka, and A. Takahashi Chylomicron remnants induce monocyte chemoattractant protein-1 expression via p38 MAPK activation in vascular smooth muscle cells Atherosclerosis 171 2003 193 200
83. Y. Takahashi, Y. Fujioka, T. Takahashi, K. Domoto, A. Takahashi, and T. Taniguchi Chylomicron remnants regulate early growth response factor-1 in vascular smooth muscle cells Life Sci 77 2005 670 682
84. B.D. Lamon, B.D. Summers, A.M. Gotto Jr., and D.P. Hajjar Pitavastatin suppresses mitogen activated protein kinase-mediated Erg-1 induction in human vascular smooth muscle cells Eur J Pharmacol 606 2009 72 76
85. A. Kawakami, A. Tanaka, T. Chiba, K. Nakajima, K. Shimokado, and M. Yoshida Remnant lipoprotein-induced smooth muscle cell proliferation involves epidermal growth factor receptor transactivation Circulation 108 2003 2679 2688
86. S. Delbosc, M. Glorian, A.S. Le Port, G. Béréziat, M. Andréani, and I. Limon The benefit of docosahexanoic acid on the migration of vascular smooth muscle cells is partially dependent on Notch regulation of MMP-2/-9 Am J Pathol 172 2008 1430 1440
87. I. Tabas, K.J. Williams, and J. Boren Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications Circulation 116 2007 1832 1844
88. C.P. Wheeler-Jones, C.E. Farrar, and A.A. Pitsillides Targeting hyaluronan of the endothelial glycocalyx for therapeutic intervention Curr Opin Investig Drugs 11 2010 997 1006
89. B.M. van den Berg, J.A. Spaan, and H. Vink Impaired glycocalyx barrier properties contribute to enhanced intimal low-denisty lipoprotein accumulation at the carotid artery bifurcation in mice Pflugers Arch 457 2009 1199 1206
90. B.G. Nordestgaard, R. Wootton, and B. Lewis Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo. Molecular size as a determinant of fractional loss from the intima-inner media Arterioscler Thromb Vasc Biol 15 1995 534 542
91. A. von Eckardstein, and L. Rohrer Transendothelial lipoprotein transport and regulation of endothelial permeability and integrity by lipoproteins Curr Opin Lipidol 20 2009 197 205
92. H.A. Lehr, and K. Messmer The microcirculation in atherogenesis Cardiovasc Res 32 1996 781 788
93. A.M. Beyer, and D.D. Gutterman Regulation of the human coronary microcirculation J Mol Cell Cardiol 52 2012 814 821
94. E. Constantinescu, D. Alexandru, V. Alexandru, M. Raicu, and M. Simionescu Endothelial cell-derived foam cells fail to express adhesion molecules (ICAM-1 and VCAM-1) for monocytes J Submicrosc Cytol Pathol 32 2000 195 201
95. C. Flood, M. Gustafsson, P.E. Richardson, S.C. Harvey, J.P. Segrest, and J. Borén Identification of the proteoglycan binding site in apolipoprotein B48 J Biol Chem 277 2002 32228 32233
96. I.J. Goldberg, W.D. Wagner, L. Pang, L. Paka, L.K. Curtiss, and J.A. DeLozier The NH2-terminal region of apolipoprotein B is sufficient for lipoprotein association with glycosaminoglycans J Biol Chem 273 1998 35355 35361
97. J. Huber, A. Vales, G. Mitulovic, M. Blumer, R. Schmid, and J.L. Witztum Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions Arterioscler Thromb Vasc Biol 22 2002 101 107
98. V.N. Bochkov, O.V. Oskolkova, K.G. Birukov, A.L. Levonen, C.J. Binder, and J. Stöckl Generation and biological activities of oxidized phospholipids Antioxid Redox Signal 12 2010 1009 1059
99. I. Staprãns, J.H. Rapp, X.M. Pan, K.Y. Kim, and K.R. Feingold Oxidized lipids in the diet are a source of oxidized lipid in chylomicrons of human serum Arterioscler Thromb 14 1994 1900 1905
100. M. Evans, Y. Berhane, K.M. Botham, J. Elliott, and C.P. Wheeler-Jones Chylomicron-remnant-like particles modify production of vasoactive mediators by endothelial cells Biochem Soc Trans 32 2004 110 112
101. O.V. Oskolkova, T. Afonyushkin, B. Preinerstorfer, W. Bicker, E. von Schlieffen, and E. Hainzl Oxidized phospholipids are more potent antagonists of lipopolysaccharide than inducers of inflammation J Immunol 15 185 2010 7706 7712
102. S.S. Hamdulay, B. Wang, G.M. Birdsey, F. Ali, O. Dumont, and P.C. Evans Celecoxib activates PI-3K/Akt and mitochondrial redox signaling to enhance heme oxygenase-1-mediated anti-inflammatory activity in vascular endothelium Free Radic Biol Med 48 2010 1013 1023
103. S. Lee, R. Li, B. Kim, R. Palvolgyi, T. Ho, and Q.Z. Yang Ox-PAPC activation of PMET system increases expression of heme oxygenase-1 in human aortic endothelial cell J Lipid Res 50 2009 265 274
104. V.N. Bochkov, M. Philippova, O. Oskolkova, A. Kadl, A. Furnkranz, and E. Karabeg Oxidized phospholipids stimulate angiogenesis via autocrine mechanisms, implicating a novel role for lipid oxidation in the evolution of atherosclerotic lesions Circ Res 99 2006 900 908
105. F. Syeda, J. Grosjean, R.A. Houliston, R.J. Keogh, T.D. Carter, and E. Paleolog Cyclooxygenase-2 induction and prostacyclin release by protease-activated receptors in endothelial cells require cooperation between mitogen-activated protein kinase and NF-kappaB pathways J Biol Chem 28 281 2006 11792 11804
106. E. Garonna, K.M. Botham, G.M. Birdsey, A.M. Randi, R.R. Gonzalez-Perez, and C.P. Wheeler-Jones Vascular endothelial growth factor receptor-2 couples cyclo-oxygenase-2 with pro-angiogenic actions of leptin on human endothelial cells PLoS One 6 2011 e18823
107. S. Kawasaki, T. Taniguchi, Y. Fujioka, A. Takahashi, T. Takahashi, and K. Domoto Chylomicron remnant induces apoptosis in vascular endothelial cells Ann NY Acad Sci 902 2000 336 341
108. H.K. Shin, Y.K. Kim, K.Y. Kim, J.H. Lee, and K.W. Hong Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein receptor-1 activation: prevention by cilostazol Circulation 109 2004 1022 1028
109. G.D. Norata, L. Grigore, S. Raselli, L. Redaelli, A. Hamsten, and F. Maggi Post-prandial endothelial dysfunction in hypertriglyceridemic subjects: molecular mechanisms and gene expression studies Atherosclerosis 193 2007 321 327
110. A. Ceriello, L. Quagliaro, L. Piconi, R. Assaloni, R. Da Ros, and Maier Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment Diabetes 53 2004 701 710
111. A. Kawakami, M. Aikawa, P. Alcaide, F.W. Luscinskas, P. Libby, and F.M. Sacks Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells Circulation 114 2006 681 687
112. G.D. Norata, A. Pirillo, E. Callegari, A. Hamsten, A.L. Catapano, and P. Eriksson Gene expression and intracellular pathways involved in endothelial dysfunction induced by VLDL and oxidised VLDL Cardiovasc Res 59 2003 169 180
113. A.M. Sawka, R.J. Singh, H.J. Hiddinga, J.P. McConnell, N.L. Eberhardt, and N.M. Caplice Remnant lipoproteins induce endothelial plasminogen activator inhibitor-1 Biochem Biophys Res Commun 285 2001 15 19
114. A. Jaulmes, P. Sansilvestri-Morel, G. Rolland-Valognes, F. Bernhardt, R. Gaertner, and B.P. Lockhart Nox4 mediates the expression of plasminogen activator inhibitor-1 via p38 MAPK pathway in cultured human endothelial cells Thromb Res 124 2009 439 446
115. G.D. Norata, C. Banfi, A. Pirillo, E. Tremoli, A. Hamsten, and A.L. Catapano Oxidised-HDL3 induces the expression of PAI-1 in human endothelial cells. Role of p38MAPK activation and mRNA stabilization Br J Haematol 127 2004 97 104
116. S. Morimoto, Y. Fujioka, H. Hosoai, T. Okumura, M. Masai, and T. Sakoda The renin-angiotensin system is involved in the production of plasminogen activator inhibitor type 1 by cultured endothelial cells in response to chylomicron remnants Hypertens Res 26 2003 315 323
117. L. Liu, T. Wen, X.Y. Zheng, D.G. Yang, S.P. Zhao, and D.Y. Xu Remnant-like particles accelerate endothelial progenitor cells senescence and induce cellular dysfunction via an oxidative mechanism Atherosclerosis 202 2009 405 414
118. D.G. Yang, L. Liu, S.H. Zhou, M.F. Ma, and T. Wen Remnant-like lipoproteins may accelerate endothelial progenitor cells senescence through inhibiting telomerase activity via the reactive oxygen species-dependent pathway Can J Cardiol 27 2011 628 634
119. Y.M. Pacheco, R. Abia, J.S. Perona, M. Reina, V. Ruiz-Gutiérrez, and E. Montero Triacylglycerol-rich lipoproteins interact with human vascular cells in a lipid-dependent fashion J Agric Food Chem 49 2001 5653 5661
120. S.Y. Park, J.H. Lee, Y.K. Kim, C.D. Kim, B.Y. Rhim, and W.S. Lee Cilostazol prevents remnant lipoprotein particle-induced monocyte adhesion to endothelial cells by suppression of adhesion molecules and monocyte chemoattractant protein-1 expression via lectin-like receptor for oxidized low-density lipoprotein receptor activation J Pharmacol Exp Ther 312 2005 1241 1248
121. L. Wang, A.R. Sapuri-Butti, H.H. Aung, A.N. Parikh, and J.C. Rutledge Triglyceride-rich lipoprotein lipolysis increases aggregation of endothelial cell membrane microdomains and produces reactive oxygen species Am J Physiol Heart Circ Physiol 295 2008 H237 H244
122. N. Yoshimura, M. Kinoshita, and T. Teramoto Isolation and characterization of apolipoprotein B48-containing lipoproteins with a monoclonal antibody against apolipoprotein B48 J Atheroscler Thromb 16 2009 740 747
123. P.V. Usatyuk, and V. Natarajan Hydroxyalkenals and oxidized phospholipids modulation of endothelial cytoskeleton, focal adhesion and adherens junction proteins in regulating endothelial barrier function Microvasc Res 83 2012 45 55
124. L. Eiselein, D.W. Wilson, M.W. Lamé, and J.C. Rutledge Lipolysis products from triglyceride-rich lipoproteins increase endothelial permeability, perturb zonula occludens-1 and F-actin, and induce apoptosis Am J Physiol Heart Circ Physiol 292 2007 H2745 H2753
125. L. Wang, R. Gill, T.L. Pedersen, L.J. Higgins, J.W. Newman, and J.C. Rutledge Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation J Lipid Res 50 2009 204 213
126. M.A. Ruby, B. Goldenson, G. Orasanu, T.P. Johnston, J. Plutzky, and R.M. Krauss VLDL hydrolysis by LPL activates PPAR-alpha through generation of unbound fatty acids J Lipid Res 51 2010 2275 2281
127. W. Ahmed, G. Orasanu, V. Nehra, L. Asatryan, D.J. Rader, and O. Ziouzenkova High-density lipoprotein hydrolysis by endothelial lipase activates PPARalpha: a candidate mechanism for high-density lipoprotein-mediated repression of leukocyte adhesion Circ Res 98 2006 490 498
128. O. Ziouzenkova, S. Perrey, L. Asatryan, J. Hwang, K.L. MacNaul, and D.E. Moller Lipolysis of triglyceride-rich lipoproteins generates PPAR ligands: evidence for an antiinflammatory role for lipoprotein lipase Proc Natl Acad Sci USA 100 2003 2730 2735
129. M. Simionescu Implications of early structural-functional changes in the endothelium for vascular disease Arterioscler Thromb Vasc Biol 27 2007 266 274
130. E.A. Schwartz, and P.D. Reaven Lipolysis of triglyceride-rich lipoproteins, vascular inflammation, and atherosclerosis Biochim Biophys Acta 1821 2012 858 866
131. C.M. Williams, P.A. Bateman, K.G. Jackson, and P. Yaqoob Dietary fatty acids and chylomicron synthesis and secretion Biochem Soc Trans 32 2004 55 58
132. J.S. Perona, J. Martínez-González, J.M. Sanchez-Domínguez, L. Badimon, and V. Ruiz-Gutierrez The unsaponifiable fraction of virgin olive oil in chylomicrons from men improves the balance between vasoprotective and prothrombotic factors released by endothelial cells J Nutr 134 2004 3284 3289
133. E. Sánchez-Galán, A. Gómez-Hernández, C. Vidal, J.L. Martín-Ventura, L.M. Blanco-Colio, and B. Muñoz-García Leukotriene B4 enhances the activity of nuclear factor-kappaB pathway through BLT1 and BLT2 receptors in atherosclerosis Cardiovasc Res 81 2009 216 225
134. J.B. Wan, L.L. Huang, R. Rong, R. Tan, J. Wang, and J.X. Kang Endogenously decreasing tissue n-6/n-3 fatty acid ratio reduces atherosclerotic lesions in apolipoprotein E-deficient mice by inhibiting systemic and vascular inflammation Arterioscler Thromb Vasc Biol 30 2010 2487 2494
135. C.K. Armah, K.G. Jackson, I. Doman, L. James, F. Cheghani, and A.M. Minihane Fish oil fatty acids improve postprandial vascular reactivity in healthy men Clin Sci (Lond) 114 2008 679 686
136. A. Mishra, A. Chaudhary, and S. Sethi Oxidized omega-3 fatty acids inhibit NF-kappaB activation via a PPARalpha-dependent pathway Arterioscler Thromb Vasc Biol 24 2004 1621 1627
137. Z. Majkova, J. Layne, M. Sunkara, A.J. Morris, M. Toborek, and B. Hennig Omega-3 fatty acid oxidation products prevent vascular endothelial cell activation by coplanar polychlorinated biphenyls Toxicol Appl Pharmacol 251 2011 41 49
138. Y. Wu, C. Zhang, Y. Dong, S. Wang, P. Song, and B. Viollet Activation of the AMP-activated protein kinase by eicosapentaenoic acid (EPA, 20:5 n-3) improves endothelial function in vivo PLoS One 7 2012 e35508
139. Y.J. Surh, J.K. Kundu, and H.K. Na Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals Planta Med 74 2008 1526 1539
140. K. Schröder, M. Zhang, S. Benkhoff, A. Mieth, R. Pliquett, and J. Kosowski Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase Circ Res 110 2012 1217 1225
141. G.J. Randolph The fate of monocytes in atherosclerosis J Thromb Haemost 7 Suppl. 1 2009 28 30
142. P. Saha, B. Modarai, J. Humphries, K. Mattock, M. Waltham, and K.G. Burnand The monocyte/macrophage as a therapeutic target in atherosclerosis Curr Opin Pharmacol 9 2009 109 118
143. L.M. Varela, A. Ortega, B. Bermudez, S. Lopez, Y.M. Pacheco, and J. Villar A high fat meal promotes lipid-load and apolipoprotein B-48 receptor transcriptional activity in circulating monocytes Am J Clin Nutr 93 2011 918 925
144. B. Bermudez, S. Lopez, L.M. Varela, A. Ortega, Y.M. Pacheco, and W. Moreda Triglyceride-rich lipoprotein regulates APOB48 receptor gene expression in human THP-1 monocytes and macrophages J Nutr 142 2012 227 232
145. L.J. den Hartich, J.E. Connolly-Rohrbach, S. Fore, T.R. Huser, and J.C. Rutledge Fatty acids from very low-density lipoprotein lipolysis products induce lipid droplet accumulation in human monocytes J Immunol 184 2010 3927 3936
146. A. Alipour, A.J. van Oostrum, A. Izraeljan, C. Verseyden, J.M. Collins, and K.N. Frayn Leukocyte activation by triglyceride-rich lipoproteins Aterioscler Thromb Vasc Biol 28 2008 792 797
147. R.M. Gower, H. Wu, G.A. Foster, S. Devaraj, I. Jialal, and C.M. Ballantyne CD11c/CD18 expression is upregulated on blood monocytes during hypertriglyceridemia and enhances adhesion to vascular cell adhesion molecule-1 Atrerioscler Thromb Vasc Biol 31 2011 160 166
148. A.J. van Oostrum, J.P. van Kijk, T.P. Sijmonsma, T.J. Rabelink, and Cabezas M. Castro Increased epression of activation markers on monocytes and neutrophils in type 2 diabetes Neth J Med 2004 62 2004 320 325
149. A. van Oostrum, T.J. Rabelink, C. Verseyden, T.P. Sijmonsma, H.W. Plokker, and P.P. De Jaegere Activation of leukocytes by postprandial lipemia in healthy volunteers Atherosclerosis 177 2004 175 182
150. A. Kawakami, A. Tanaka, K. Nakajima, K. Shimokado, and M. Yoshida Atorvastatin attenuates remnant lipoprotein-induced monocyte adhesion to vascular under flow conditions Circ Res 91 2002 263 271
151. A. Kawakami, M. Aikawa, P. Libby, P. Alcaide, F.W. Luscinskas, and F.M. Sacks Apolipoprotein CIII in apolipoprotein B lipoproteins enhances the adhesion of human monocytic cells to endothelial cells Circulation 113 2006 691 700
152. A. Kawakami, M. Aikawa, N. Nitta, M. Yoshida, P. Libby, and F.M. Sacks Apolipoprotein CIII-induced THP-1 cell adhesion to endothelial cells involves pertussis toxin-sensitive G protein- and protein kinase C alpha-mediated nuclear factor-kappaB activation Arterioscler Thromb Vasc Biol 27 2007 219 225
153. A. Kawakami, M. Osaka, M. Aikawa, S. Uematsu, S. Akira, and P. Libby Toll-like receptor 2 mediates apolipoprotein CIII-induced monocyte activation Circ Res 103 2008 1402 1409
154. K. Hiramoto, and S. Arimori Increased superoxide production by mononuclear cells of patients with hypertrigyceridemia and diabetes Diabetes 37 1988 832 837
155. C. Bellido, J. López-Miranda, L.M. Blanco-Colio, P. Pérez-Martínez, F.J. Muriana, and J.L. Martín-Ventura Butter and walnuts, but not olive oil, elicit postprandial activation of nuclear transcription factor-κB in peripheral blood mononuclear cells from healthy men Am J Clin Nutr 80 2004 1487 1491
156. M.A. Carluccio, M.A. Ancora, M. Massaro, M. Carluccio, E. Scoditti, and A. Distante Homocysteine induces VCAM-1 gene expression through NF-kappaB and NAD(P)H oxidase activation: protective role of Mediterranean diet polyphenolic antioxidants Am J Physiol 293 2007 H2344 H2354
157. R.E. Gerszten, E.A. Garcia-Zepeda, Y.C. Lim, M. Yoshida, H.A. Ding, and M.A. Gimbrone MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions Nature 398 1999 718 723
158. S. Armengol Lopez, K.M. Botham, and C. Lawson The oxidative state of chylomicron remnants influences their modulation of human monocyte activation Int J Vasc Med 2012 [article ID 942512, doi: http://dx.doi.org/10.1155/2012/ 942512 ]
159. R. Clarke, and J. Armitage Antioxidant vitamins and risk of cardiovascular disease. Review of large scale randomised trials Cardiovasc Drugs Ther 1 2002 411 415
160. V.S. Graham, C. Lawson, C.P.D. Wheeler-Jones, J.S. Perona, and V. Ruiz-Gutierrez Botham KM. Triacylglycerol-rich lipoproteins derived from olive oil modulate cytokine secretion and cyclooxygenase-2 expression in macrophages: the potential role of oleanolic acid Eur J Nutr 21 2012 871 878
161. S. Tomono, S. Kawazu, N. Kato, T. Ono, C. Ishii, and Y. Ito Uptake of remnant-like praticles (RLP) in diabetic patients from mouse peritoneal macrophages J Atertheroscler Thromb 1 1994 98 102
162. F. Bejta, E.H. Moore, M. Avella, P.J. Gough, K.E. Suckling, and K.M. Botham Oxidation of chylomicron remnant-like particles inhibits their uptake by THP-1 macrophages by apolipoprotein E dependent processes Biochim Biophys Acta 1771 2007 901 910
163. K.V. Batt, L. Patel, K.M. Botham, and K.E. Suckling Chylomicron remnants and low density lipoprotein have differential effects on the expression of mRNA for genes involved in human macrophage formation J Mol Med 82 2004 449 458
164. E.H. Moore, F. Bejta, M. Avella, K.E. Suckling, and K.M. Botham Efflux of lipid from macrophages after induction of lipid accumulation by chylomicron remnants Biochim Biophys Acta 1735 2005 20 29
165. B.S. Dhaliwal, and U.P. Steinbrecher Cholesterol delivered to macrophages by oxidized low density lipoprotein is sequestered in lysosomes and fails to efflux normally J Lipid Res 41 2000 1658 1665
166. P.G. Yancey, and W.G. Jerome Lysosomal cholesterol derived from mildly oxidized low density lipoprotein is resistant to efflux J Lipid Res 42 2001 317 327
167. A. Keys, J.T. Anderson, and F. Grande Serum cholesterol response to changes in the diet IV. Particular saturated fatty acids in the diet Metabolism 14 1965 776 787
168. J.J. Moreno, and M.T. Mitjavila The degree of unsaturation of dietary fatty acids and the development of atherosclerosis (review) J. Nutr. Biochem 14 2003 182 195
169. C. De Pascale, M. Avella, J.S. Perona, V. Ruiz-Gutierrez, C.P.D. Wheeler-Jones, and K.M. Botham The fatty acid composition of chylomicron remnant-like particles influences their uptake and induction of lipid accumulation in macrophages FEBS J 273 2006 5632 5640
170. C. De Pascale, V. Graham, R.C. Fowkes, and C.P.D. Wheeler-Jones Botham KM (2009) Suppression of nuclear factor-κB activity in macrophages by chylomicron remnants: modulation by the fatty acid composition of the particles FEBS J 276 2009 5689 5702
171. Y. Jinno, M. Nakakuki, H. Kawano, T. Notsu, K. Mizuguchi, and K. Imada Eicosapentaenoic acid administration attenuates the pro-inflammatory properties of VLDL by decreasing its susceptibility to lipoprotein lipase in macrophages Atherosclerosis 219 2011 566 572
172. E.H. Moore, M. Napolitano, M. Avella, F. Bejta, K.E. Suckling, and E. Bravo Protection of chylomicron remnants from oxidation by incorporation of probucol into the particles enhances their uptake by human macrophages and increases lipid accumulation in the cells Eur J Biochem 271 2004 2417 2427
173. E.H. Moore, M. Napolitano, A. Prosperi, M. Avella, K.E. Suckling, and E. Bravo Incorporation of lycopene into chylomicron remnant-like particles enhances their induction of lipid accumulation in macrophages Biochem Biophys Res Commun 312 2003 1216 1219
174. V.S. Graham, P. Di Maggio, S. Armengol, C. Lawson, C.P. Wheeler-Jones, and K.M. Botham Inhibition of macrophage inflammatory cytokine secretion by chylomicron remnants is dependent on their uptake by the low density lipoprotein receptor Biochim Biophys Acta 1811 2011 209 220
175. M. Suzukawa, M. Abbey, P. Clifton, and P.J. Nestel Effects of supplementing with vitamin E on the uptake of low density lipoprotein and the stimulation of cholesteryl ester formation in macrophages Atherosclerosis 110 1994 77 86
176. A. Yamamoto, H. Hara, S. Takaichi, S. Wakasugi, and M. Tomikawa Effect of probucol on macrophages, leading to regression of xanthomas and atheromatous vascular lesions Am J Cardiol 62 1988 31B 36B
177. R. Stocker Dietary and pharmacological antioxidants in atherosclerosis Curr Opin Lipidol 10 1999 589 597
178. M. Napolitano, and E. Bravo Evidence of dual pathways for lipid uptake during chylomicron remnant-like particle processing by human macrophages J Vasc Res 43 2006 355 366
179. E. Bravo, and M. Napolitano Mechanisms involved in chylomicron remnant lipid uptake by macrophages Biochem Soc Trans 35 2007 459 463
180. M. Napolitano, H.S. Kruth, and E. Bravo Phospholipase A2 mediates apolipoprotein-independent uptake of chylomicron remnant-like particles by human macrophages Int J Vasc Med 2012 [article ID 501954, doi: http://dx.doi.org/10. 1155/2012/501954
181. Y. Fujioka, A.D. Cooper, and L.G. Fong Multiple processes are involved in the uptake of chylomicron remnants by mouse peritoneal macrophages J Lipid Res 39 1998 2339 2349
182. S. Takahashi, S. Ito, Y. Zenimaru, J. Suzuki, I. Miyamori, and M. Takahashi Species differences of macrophage very low-density-lipoprotein (VLDL) receptor protein expression Biochem Biophys Res Commun 407 2011 656 662
183. S. Takahashi, J. Suzuki, M. Kohno, K. Oida, T. Tamai, and S. Miyabo Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase J Biol Chem 270 1995 15747 15754
184. M.L. Brown, M.P. Ramprasad, P.K. Umeda, A. Tanaka, Y. Kobayashi, and T. Watanabe A macrophage receptor for apolipoprotein B48: cloning, expression, and atherosclerosis Proc Natl Acad Sci USA 97 2000 7488 7493
185. A. Kawakami, M. Tani, T. Chiba, K. Yui, S. Shinozaki, and K. Nakajima Pitavastatin inhibits remnant lipoprotein induced macrophage foam cell formation through apoB48 receptor-dependent mechanism Arterioscler Thromb Vasc Biol 25 2005 424 429
186. G. Haraguchi, Y. Kobayashi, M.L. Brown, A. Tanaka, M. Isobe, and S.H. Gianturco PPAR(alpha) and PPAR(gamma) actviators suppress the monocyte-macrophage apo-B48 receptor J Lipid Res 44 2003 1224 1231
187. A.C. Nicholson Expression of CD36 in macrophages and atherosclerosis: the role of lipid regulation of PPARgamma signaling Trends Cardiovasc Med 14 2004 8 12
188. M.F. Linton, and S. Fazio Class A scavenger receptors, macrophages and atherosclerosis Curr Opin Lipidol 12 2001 489 495
189. M. Napolitano, and E. Bravo Lipid metabolism and TNF-alpha secretion in response to dietary sterols in human monocyte derived macrophages Eur J Clin Invest 35 2005 482 490
190. A. Fredenrich, and P. Bayer Reverse cholesterol transport, high density lipoproteins and HDL cholesterol: recent data Diabetes Metab 29 2003 201 205
191. A.N. Palmer, E. Nova, A. Anil, K. Jackson, P. Bateman, and E. Wolstencroft Differential uptake of subfractions of triglyceride-rich lipoproteins by THP-1 macrophages Atheroscerosis 180 2005 233 244
192. V. Saraswathy, and A.H. Hasty The role of lipolysis in mediating the proinflammatory effects of very low density lipoproteins in mouse peritoneal macrophages J Lipid Res 47 2006 1406 1415
193. D. Milosavljevic, A. Kontush, S. Griglio, G. LeNaour, J. Thillet, and M.J. Chapman VLDL-induced triglyceride accumulation in human macrophages is mediated by modulation of LPL lipolytic activity in the absence of change in LPL mass Biochim Biophys Acta 1631 2003 51 60
194. J.C. Mamo, C.L. Elsegood, H.C. Gennat, and K. Yu Degradation of chylomicron remnants by macrophages occurs via phagocytosis Biochemistry 35 1996 10210 10214
195. C.L. Elsegood, and J.C. Mamo An investigation by electron microscopy of chylomicron remnant uptake by human monocyte-derived macrophages Atherosclerosis 188 2006 251 259
196. J. Genest C-reactive protein: risk factor, biomarker and/or therapeutic target? Can J Cardiol 26 Suppl. A 2010 41A 44A
197. S.A. Tsimikas, and Y.I. Miller Oxidative modification of lipoproteins: mechanisms, role in inflammation and potential clinical applications in cardiovascular disease Curr Pharm Des 17 2011 27 37
198. R.L. Tiwari, V. Singh, and M.K. Barthwal Macrophages, an elusive yet emerging therapeutic target of atherosclerosis Med Res Rev 28 2008 483 544
199. M.M. Stollenwerk, A. Schiopu, G.N. Fredrikson, W. Dichtl, J. Nilsson, and M.P. Ares Very low density lipoprotein potentiates tumor necrosis factor-alpha expression in macrophages Atherosclerosis 179 2005 247 254
200. M.M. Stollenwerk, M.W. Lindholm, M.I. Porn-Ares, A. Larrson, J. Nilsson, and M.P. Ares Very low-density lipoprotein induces interleukin-1 beta expression in macrophages Biochem Biophys Res Commun 335 2005 603 608
201. J. Persson, J. Nilsson, and M.W. Lindholm Cytokine response to lipoprotein lipid loading in human monocyte-derived macrophages Lipids Health Dis 5 2006 17 10.1186/1476-511X-5-17
202. A. Marquez-Martin, R. De La Puerta, A. Fernandez-Arche, V. Ruiz-Gutierrez, and P. Yaqoob Modulation of cytokine secretion by pentacyclic triterpenes from olive pomace oil in human mononuclear cells Cytokine 36 2006 211 217
203. T. Okumura, Y. Fujioka, S. Morimoto, M. Masai, T. Sakoda, and T. Tsujino Chylomicron remnants stimulate release of interleukin-1beta by THP-1 cells J Atheroscler Thromb 13 2006 38 45
204. M.D. Li, and X. Yang A retrospective on nuclear receptor regulation of inflammation: lessons from GR and PPARs PPAR Res 2011 2011 742785
205. M. Karin The beginning of the end: IkappaB kinase (IKK) and NF-kB activation J Biol Chem 274 1999 27339 27342
206. S.M. Weldon, A.C. Mullen, C.E. Loscher, L.A. Hurley, and H.M. Roche Docosahexaenoic acid induces an anti-inflammatory profile in lipopolysaccharide stimulated human THP-1 macrophages more effectively than eicosapentaenoic acid J Nutr Biochem 18 2007 250 258
207. W. Komatsu, K. Ishihara, M. Murata, H. Saito, and K. Shinohara Docosahexaenoic acid suppresses nitric oxide production and inducible nitric oxide synthase expression in interferon-gamma plus lipopolysaccharide-stimulated murine macrophages by inhibiting the oxidative stress Free Radic Biol Med 34 2003 1006 1016
208. M.M. Rahmann, A. Bhattacharya, and G. Fernandez Docosahexaenoic acid is a more potent inhibitor of osteoclast differentiation in RAW 264.7 cells than eicosapentaenoic acid J Cell Physiol 214 2008 201 209
209. F. Porcheray, S. Viaud, A.C. Rimaniol, C. Leone, B. Samah, and N. Dereuddre-Bosquet Macrophage activation switching: an asset for the resolution of inflammation Clin Exp Immunol 2005 142 2005 481 489
210. A. Varin, and S. Gordon Alternative activation of macrophages: immune function and cellular biology Immunobiology 214 2009 630 641
211. A. Kadl, A.K. Meher, P.R. Sharma, M.Y. Lee, A.C. Doran, and S.R. Johnstone Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2 Circ Res 107 2010 737 746
212. D. Baitsch, H.H. Bock, T. Engel, R. Telgmann, C. Muller-Tidow, and G. Varga Apolipoprotein E induces anti-inflammatory phenotype in macrophages Arterioscler Thromb Vasc Biol 31 2011 1160 1168
213. J.S. Volek, D.A. Judelson, R. Silvestre, L.M. Yamamoto, B.A. Spiering, and D.L. Hatfield Effects of carnitine supplementation on flow-mediated dilation and vascular inflammatory responses to a high-fat meal in healthy young adults Am J Cardiol 102 2008 1413 1417
214. B. Burton-Freeman, J. Talbot, E. Park, S. Krishnankutty, and I. Edirisinghe Protective activity of processed tomato products on postprandial oxidation and inflammation: a clinical trial in healthy weight men and women Mol Nutr Food Res 56 2012 622 631